Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl

Germline mutations in Fas and Fasl induce nonmalignant T cell hyperplasia and systemic autoimmunity and also greatly increase the risk of B cell neoplasms. B lymphomas occurring in Fasl mutant (gld) mice usually are immunoglobulin (Ig) isotype switched, secrete Ig, and are plasmacytoid in appearance but lack Myc translocations characteristic of other plasma cell (PC) neoplasms. Here, we explore the relationship between B cell autoreactivity and transformation and use gene expression profiling to further classify gld plasmacytoid lymphomas (PLs) and to identify genes of potential importance in transformation. We found that the majority of PLs derive from antigen-experienced autoreactive B cells producing antinuclear antibody or rheumatoid factor and exhibit the skewed Ig V gene repertoire and Ig gene rearrangement patterns associated with these specificities. Gene expression profiling revealed that both primary and transplanted PLs share a transcriptional profile that places them at an early stage in PC differentiation and distinguishes them from other B cell neoplasms. In addition, genes were identified whose altered expression might be relevant in lymphomagenesis. Our findings provide a strong case for targeted transformation of autoreactive B cells in gld mice and establish a valuable model for understanding the relationship between systemic autoimmunity and B cell neoplasia.

[1]  Takeshi Suzuki,et al.  High-Throughput Retroviral Tagging for Identification of Genes Involved in Initiation and Progression of Mouse Splenic Marginal Zone Lymphomas , 2004, Cancer Research.

[2]  H. Xin,et al.  Interleukin-6 Induces Expression of Ifi202, an Interferon-inducible Candidate Gene for Lupus Susceptibility* , 2004, Journal of Biological Chemistry.

[3]  E. Schattner,et al.  Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL. , 2004, The Journal of Immunology.

[4]  K. Tarte,et al.  BAFF and APRIL protect myeloma cells from apoptosis induced by IL-6 deprivation and dexamethasone , 2003 .

[5]  B. Harder,et al.  Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. , 2004, Blood.

[6]  R. Bende,et al.  Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. , 2003, Cancer research.

[7]  K. Tarte,et al.  Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. , 2003, Blood.

[8]  S. Levy,et al.  Hepatitis C Virus (HCV) and Lymphomagenesis , 2003, Leukemia & lymphoma.

[9]  H. Groux,et al.  The complex role of interleukin-10 in autoimmunity. , 2003, Journal of autoimmunity.

[10]  Gregory H Underhill,et al.  Gene expression profiling reveals a highly specialized genetic program of plasma cells. , 2003, Blood.

[11]  N. Kakazu,et al.  Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.

[12]  W. Klapper,et al.  Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. , 2003, Blood.

[13]  Chad W. Euler,et al.  Activation of Rheumatoid Factor (RF) B Cells and Somatic Hypermutation Outside of Germinal Centers in Autoimmune‐Prone MRL/lpr Mice , 2003, Annals of the New York Academy of Sciences.

[14]  Chen-feng Qi,et al.  B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders. , 2003, Advances in immunology.

[15]  Reuben S Harris,et al.  RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.

[16]  M. Teitell,et al.  PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling , 2002, Nature Immunology.

[17]  M. Monestier,et al.  Receptor Revision and Systemic Lupus , 2002, Scandinavian journal of immunology.

[18]  A. Carbone,et al.  Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus‐associated non‐Hodgkins's lymphomas , 2002, European journal of immunology.

[19]  M. Du,et al.  Mucosa-associated lymphoid tissue lymphoma , 2002, Current opinion in hematology.

[20]  M. Teitell,et al.  PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. , 2002, Nature immunology.

[21]  A. Feeney,et al.  Unusual Germline DSP2 Gene Accounts for All Apparent V-D-D-J Rearrangements in Newborn, But Not Adult, MRL Mice1 , 2001, The Journal of Immunology.

[22]  M. Radic,et al.  Editors and editing of anti-DNA receptors. , 2001, Immunity.

[23]  X. Mariette Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells , 2001, Annals of the rheumatic diseases.

[24]  G. Peltz,et al.  Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. , 2001, Immunity.

[25]  A. Marx,et al.  The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. , 2001, Blood.

[26]  Carl W. Miller,et al.  Mutations in the mitotic check point gene, MAD1L1, in human cancers , 2001, Oncogene.

[27]  E. Jaffe,et al.  Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. , 2001, Blood.

[28]  H. Doyle,et al.  Lupus autoantigens: Their origins, forms, and presentation , 2001, Immunologic research.

[29]  B. Haines,et al.  Germline diversity of the expressed BALB/c VhJ558 gene family. , 2001, Molecular immunology.

[30]  A. Carbone,et al.  Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. , 2000, Blood.

[31]  R. Tibshirani,et al.  The Inference of Antigen Selection on Ig Genes1 , 2000, The Journal of Immunology.

[32]  M. Monestier,et al.  Heavy Chain Revision in MRL Mice: A Potential Mechanism for the Development of Autoreactive B Cell Precursors1 , 2000, The Journal of Immunology.

[33]  Ash A. Alizadeh,et al.  Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. D. Capra,et al.  Receptor Revision of Immunoglobulin Heavy Chain Variable Region Genes in Normal Human B Lymphocytes , 2000, The Journal of experimental medicine.

[35]  A. Soley,et al.  Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. , 2000, Arthritis and rheumatism.

[36]  P. Gorevic,et al.  Hepatitis C virus, autoimmunity and lymphoproliferation. , 2000, The Mount Sinai journal of medicine, New York.

[37]  R. Tibshirani,et al.  Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. , 2000, Blood.

[38]  G. Prendergast,et al.  Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity , 2000, International journal of cancer.

[39]  H. Morse,et al.  Accelerated Appearance of Multiple B Cell Lymphoma Types in NFS/N Mice Congenic for Ecotropic Murine Leukemia Viruses , 2000, Laboratory Investigation.

[40]  D. Sansonno,et al.  The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. , 2000, Seminars in liver disease.

[41]  S. Litwin,et al.  Somatic Mutation and Light Chain Rearrangement Generate Autoimmunity in Anti–Single-Stranded DNA Transgenic Mrl/lpr Mice , 1999, The Journal of experimental medicine.

[42]  Wei Du,et al.  Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms , 1999, Oncogene.

[43]  C. Sokol,et al.  MRL-lpr/lpr Mice Exhibit a Defect in Maintaining Developmental Arrest and Follicular Exclusion of Anti–double-stranded DNA B Cells , 1999, The Journal of experimental medicine.

[44]  P. Casali,et al.  Clonal evolution of B cells in transformation from low‐ to high‐grade lymphoma , 1999, European journal of immunology.

[45]  P. Dejong,et al.  The imprinted domain in mouse distal Chromosome 7: reagents for mutagenesis and sequencing , 1999, Mammalian Genome.

[46]  M. Casado,et al.  Lymphoma of the gastrointestinal tract , 1998 .

[47]  T. Giese,et al.  Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas–Fas Ligand Interactions , 1998, The Journal of experimental medicine.

[48]  E. Whitcomb,et al.  Rearrangement and selection in the developing Vkappa repertoire of the mouse: an analysis of the usage of two Vkappa gene segments. , 1998, Journal of immunology.

[49]  F. E. Bertrand,et al.  Molecular mechanisms involved in receptor editing at the Ig heavy chain locus. , 1998, International immunology.

[50]  M. J. Moreno Casado,et al.  [Lymphoma of the gastrointestinal tract]. , 1998, Sangre.

[51]  K. Rajewsky,et al.  Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression , 1997, European journal of immunology.

[52]  L. Duret,et al.  Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle , 1997, Leukemia.

[53]  L. Herzenberg,et al.  An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. , 1997, Journal of immunology.

[54]  T. Marion,et al.  Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. , 1996, Journal of immunology.

[55]  A. Hayday,et al.  A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice , 1996, The Journal of experimental medicine.

[56]  Stanley N Cohen,et al.  tsg101: A Novel Tumor Susceptibility Gene Isolated by Controlled Homozygous Functional Knockout of Allelic Loci in Mammalian Cells , 1996, Cell.

[57]  T. Waldschmidt,et al.  Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. , 1996, Clinical immunology and immunopathology.

[58]  E. L. Prak,et al.  Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. , 1995, Immunity.

[59]  J. Taylor,et al.  Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Scadden,et al.  Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. , 1995, Blood.

[61]  Wen-Hsiung Li,et al.  Alternative mRNA Splicing and Differential Promoter Utilization Determine Tissue-specific Expression of the Apolipoprotein B mRNA-editing Protein (Apobec1) Gene in Mice. , 1995, The Journal of Biological Chemistry.

[62]  B. Klein,et al.  Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. , 1995, Blood.

[63]  M. Radic,et al.  Genetic and structural evidence for antigen selection of anti-DNA antibodies. , 1994, Annual review of immunology.

[64]  J Erikson,et al.  B lymphocytes may escape tolerance by revising their antigen receptors , 1993, The Journal of experimental medicine.

[65]  D. Tillman,et al.  Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice , 1992, The Journal of experimental medicine.

[66]  D. Bahler,et al.  Clonal evolution of a follicular lymphoma: evidence for antigen selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  M. Hibi,et al.  Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. , 1992, Journal of immunology.

[68]  S. Kalled,et al.  Utilization of V kappa families and V kappa exons. Implications for the available B cell repertoire. , 1991, Journal of immunology.

[69]  L. Deaven,et al.  A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. , 1991, The Journal of biological chemistry.

[70]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[71]  P. Isaacson,et al.  Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. , 1988, Human pathology.

[72]  P. Isaacson,et al.  Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. , 1988, Human pathology.

[73]  D. Pisetsky,et al.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Riblet,et al.  The immunoglobulin heavy chain variable region (Igh‐V) locus in the mouse. I. One hundred Igh‐V genes comprise seven families of homologous genes , 1984, European journal of immunology.

[75]  R. Balderas,et al.  Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice , 1983, The Journal of experimental medicine.